This paper studies how local legal and regulatory environments affect physicians’ geographic practice choices. I combine a novel state-year panel of abortion restrictions with longitudinal physician practice-location data. Reduced-form evidence shows that a one-standard-deviation increase in legal permissiveness is associated with 0.089 more annual OB/GYN arrivals per 100,000 residents relative to general surgery. A county-level discrete-choice model implies about 6.3 percent higher relative odds of choosing a county as a destination for the same increase in permissiveness, while incumbent physicians are more persistent in restrictive environments. In a counterfactual without measured net tightening since 2015, about 427 OB/GYN physician-equivalents would have been geographically reallocated across counties by 2024, with a modest shift toward counties with lower baseline OB/GYN availability.
Sheikh Atiya Islam
Ph.D. Candidate in Economics
The Pennsylvania State University
Industrial Organization · Health Economics
I am a researcher in industrial organization and health economics, with additional interests in applied microeconomics and environmental and energy economics. My research primarily focuses on how regulation, information, and market incentives shape individual and firm behavior and the allocation of resources, particularly in healthcare markets.
My job market paper, “Physicians’ Location Choice and Access to Healthcare: Case of Dobbs 2022,” studies how local legal and regulatory environments shape where physicians practice. I link a novel state-year panel of abortion restrictions to longitudinal physician practice-location data and combine reduced-form evidence with a discrete-choice model that separates destination sorting from incumbent-location persistence. More permissive legal environments attract more OB/GYN arrivals and make counties more attractive destinations, while incumbent physicians are more persistent in restrictive environments. Counterfactual policy paths imply meaningful geographic reallocation, with the resulting distribution modestly shifting physician supply toward counties with lower baseline OB/GYN availability.
My other work examines how pharmaceutical demand adjusts to new clinical information after market entry under the FDA Accelerated Approval pathway, and how electric-generating plants adjust operation, generation, and fuel use in response to carbon-pricing incentives under the Regional Greenhouse Gas Initiative.
Research
This project studies how pharmaceutical product demand adjusts to new information after market entry when uncertainty about clinical benefit remains unresolved. The FDA Accelerated Approval pathway provides a useful setting because drugs can enter the market on the basis of surrogate or intermediate endpoints before their anticipated clinical benefit has been fully verified in required confirmatory trials. I combine Medicaid State Drug Utilization data, FDA records, and a novel dataset on confirmatory-trial evidence. Using an event-study design centered on the public release of confirmatory evidence, I find that favorable evidence is followed by approximately a 47 percent increase in utilization over the first five quarters, while unfavorable evidence is followed by approximately a 38 percent decline over the same horizon and a decline of more than 50 percent over the first nine quarters. Market adjustment begins before final regulatory resolution. These results show how post-entry information can shape pharmaceutical demand and highlight the importance of timely generation and dissemination of confirmatory evidence.
This project examines how electric-generating plants adjust operation, generation, and fuel use in response to carbon-pricing incentives under the Regional Greenhouse Gas Initiative.
Teaching
Instructor of Record, The Pennsylvania State University
ECON 306: Introduction to Econometrics
ECON 104: Introductory Macroeconomic Analysis
Teaching Assistant, The Pennsylvania State University
ECON 501: Econometrics; ECON 445: Health Economics; ECON 423: Economics of Public Expenditure; ECON 422: Applied Monetary Theory and Monetary History; ECON 304: Intermediate Macroeconomic Analysis; ECON 104: Introductory Macroeconomic Analysis; ECON 102: Introductory Microeconomic Analysis.
Curriculum Vitae
View the CV directly in your browser or download the PDF.